test

Demand of Human Milk Oligosaccharides has been Increased Due to Growth in Health Awareness Across the Globe

The HMO Market is projected to reach $556 million by 2027, recording a CAGR of 22.7%.

The global HMO market has been influenced by some of the macroeconomic and microeconomic factors witnessed in some key countries. This would prove strong enough to drive the market significantly in terms of value sales during the forecast period. With the rise in number of infants across the globe, the demand and preference for HMO-based infant formula along with the trend of adopting healthy lifestyle by consuming functional food and beverages has significantly boosted the utilization of HMO in manufacturing.

https://www.marketsandmarkets.....com/Market-Reports/h

The key players in this market include DSM (Netherlands), BASF SE (Germany), Chr. Hansen Holding A/S (Denmark), DUPONT ( US), and Royal FrieslandCampina N.V. (Netherlands).

Human Milk Oligosaccharides (HMO) Market Size & Share | Growth Trends by 2022 - 2027 | MarketsandMarkets
www.marketsandmarkets.com

Human Milk Oligosaccharides (HMO) Market Size & Share | Growth Trends by 2022 - 2027 | MarketsandMarkets

[226 Pages] Human Milk Oligosaccharides (HMO) Market is anticipated to reach USD 556 million by 2027, recording a CAGR of 22.7%. Human Milk Oligosaccharides (HMO) Market report is segmented by Application (Infant Formula, Functional Food & Beverages,